-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Dallah Health posts higher net profit at SAR 136.6m for 2013
31/12/2013
Argaam Exclusive
Dallah Health Holding Co., active in the operation and management of hospitals and medical clinics, reported SAR 136.6m net profit at the end of 2013, a 2.5% increase compared to last year, as shown in the following table:
Financials (M)
| Item | 2012 | 2013 | Change |
|---|---|---|---|
| Revenues | 636.86 | 749.65 | 17.7 % |
| Gross Income | 286.87 | 327.45 | 14.1 % |
| Operating Income | 130.75 | 137.53 | 5.2 % |
| Net Income | 133.36 | 136.63 | 2.5 % |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 1.48 | 1.52 | 2.5 % |
Current Quarter Comparison (M)
| Item | Q4 2012 | Q4 2013 | Change |
|---|---|---|---|
| Revenues | 179.43 | 211.05 | 17.6 % |
| Gross Income | 81.51 | 95.71 | 17.4 % |
| Operating Income | 32.18 | 48.06 | 49.3 % |
| Net Income | 34.37 | 52.11 | 51.6 % |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 0.38 | 0.58 | 51.6 % |
View other reports
Share Price
Dallah Healthcare Co. (DALLAH HEALTH)
| Current | |
| Market Cap (M Riyal) | 14,945.04 |
| Enterprise Value (EV) (M) | 16,864.64 |
| Shares Outstanding ((M)) | 97.68 |
| EPS ( Riyal) (TTM) | 4.82 |
| Book Value (BV) ( Riyal) | 34.96 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 31.73 |
| P/E (TTM) | 31.73 |
| Price/book | 4.38 |
| Return on Average Assets (%) (TTM) | 7.5 |
| Return on Average Equity (%) (TTM) | 14.3 |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2013 | 183.73 | 19.3 % | 84.40 | 15.9 % | 38.39 | 1.0 % |
| Q2 2013 | 187.79 | 16.4 % | 80.68 | 9.4 % | 30.19 | (20.9 %) |
| Q3 2013 | 167.08 | 17.4 % | 66.67 | 13.0 % | 21.95 | (2.0 %) |
| Q4 2013 | 211.05 | 17.6 % | 95.71 | 17.4 % | 48.06 | 49.3 % |
| 2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 137.53 | 5.2 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
|---|---|---|---|---|---|---|
| Q1 2013 | 39.04 | 2.8 % | 0.43 | - | 39.04 | 0.43 |
| Q2 2013 | 23.64 | (36.3 %) | 0.26 | - | 23.64 | 0.26 |
| Q3 2013 | 21.84 | (8.7 %) | 0.24 | - | 21.84 | 0.24 |
| Q4 2013 | 52.11 | 51.6 % | 0.58 | - | 52.11 | 0.58 |
| 2013 | 136.63 | 2.5 % | 1.52 | - | 136.63 | 1.52 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2013 | 44.79 % | 24.18 % | 20.16 % |
| Q2 2013 | 44.08 % | 22.36 % | 17.45 % |
| Q3 2013 | 43.63 % | 21.80 % | 16.56 % |
| Q4 2013 | 43.68 % | 23.30 % | 18.23 % |
| 2013 | 43.68 % | 23.16 % | 18.23 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2013 | 90.00 | 1.49 | 1.49 | 12.83 |
| Q2 2013 | 90.00 | 1.34 | 1.34 | 12.37 |
| Q3 2013 | 90.00 | 1.32 | 1.32 | 12.64 |
| Q4 2013 | 90.00 | 1.52 | 1.52 | 13.22 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2013 | 23.15 | 23.15 | 2.70 |
| Q2 2013 | 26.26 | 26.26 | 2.85 |
| Q3 2013 | 26.93 | 26.93 | 2.82 |
| Q4 2013 | 26.15 | 26.15 | 3.00 |
Business Segments (Million)
Q4 2013
| Period | Medical Services | Medicine and Pharmaceutical Products |
|---|---|---|
| Q1 2013 | 169.97 | 13.76 |
| Q2 2013 | 168.24 | 19.56 |
| Q3 2013 | 158.17 | 8.92 |
| Q4 2013 | 192.80 | 18.25 |
Follow us on
Call Request
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}